0001731122-20-000024.txt : 20200108 0001731122-20-000024.hdr.sgml : 20200108 20200108180029 ACCESSION NUMBER: 0001731122-20-000024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200106 FILED AS OF DATE: 20200108 DATE AS OF CHANGE: 20200108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boenisch Sandra CENTRAL INDEX KEY: 0001655366 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37606 FILM NUMBER: 20516647 MAIL ADDRESS: STREET 1: 51 WEST 52ND STREET, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANAVEX LIFE SCIENCES CORP. CENTRAL INDEX KEY: 0001314052 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 208365999 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 51 W 52ND STREET, STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019-6163 BUSINESS PHONE: 800-689-3939 MAIL ADDRESS: STREET 1: 51 W 52ND STREET, STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019-6163 FORMER COMPANY: FORMER CONFORMED NAME: Thrifty Printing Inc. DATE OF NAME CHANGE: 20050111 4 1 ownership.xml X0306 4 2020-01-06 0 0001314052 ANAVEX LIFE SCIENCES CORP. AVXL 0001655366 Boenisch Sandra 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 0 1 0 0 PFO & Treasurer Stock Option (Right to Buy) 2.96 2020-01-06 4 A 0 70000 0 A 2030-01-06 Common Stock 70000 70000 D The options shall vest upon the achievement of a certain clinical trial milestone with respect to the Issuer's Phase 2 clinical trial program of Anavex(R)2-73 for the treatment of Rett syndrome. /s/ Sandra Boenisch 2020-01-08